Clinical Trial Update: Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Ankylosing Spondylitis (AS) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety and efficacy of umbilical cord/placenta-derived mesenchymal stem cells for ankylosing spondylitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells (mesenchymal stem cells)

Snippet

Sponsor: Shandong University | Conditions: Ankylosing Spondylitis | Phase 1 | Status: UNKNOWN